Tony Zhang

  • Vice President of Global External R&D, Elli Lilly, Shanghai, China

    Dr. Tony Zhang received his BS degree in chemistry from Shandong University, and went to the US for graduate studies as a CGP Fellow. He obtained his PhD from Purdue University, followed by a stint as a research chemist at Reilly (Vertellus) Chemicals.

    He joined Eli Lilly in 1992, and had led multi-disciplined teams engaged in drug development. He is recognized as a premier molecule builder, and has patented, published, and lectured extensively in synthetic chemistry and pharmaceutical process development. He is an advisory board member for an international journal and several nonprofit organizations, and has received a number of awards, including the highest distinction within Lilly, the Chairman Ovation Award, for his contribution to R&D productivity.

    Tony has been a key initiator and implementer of the company∏s R&D network in China. In June 2008, he assumed the current leadership role as managing director and site head for Eli Lilly Global R&D, China, with responsibilities including development of R&D strategies, establishment and management of research collaborations, and licensing activities for molecular assets and research technologies in the Greater China area.

  • Conference Info:


    Date: June 26-27, 2013
    Location: The Metropolitan Club, New York City

    Audience: Institutional investors, high net worth individual investors, family offices, business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.

    View the Schedule!

    View the Agenda!